A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models. - Ye, Zhengyu; Dai, Wenhao; Zhang, Shaolin; Xiang, Yingchun; Wang, Jinlin; Zhang, Yumin; Cao, Wenyuan; Neyts, Johan; Li, Zuyi; Feng, Fan; Xiao, Gengfu; Liu, Hong; et al. (PLoS Pathogens, 2026)